title: Therapeutic implications of innate immune system in acute pancreatitis.
abstract: BACKGROUND
  Acute pancreatitis (AP) is an inflammatory disorder of the pancreas encompassing a cascade of cellular and molecular events. It starts from premature activation of zymogens with the involvement of innate immune system to a potential systemic inflammatory response and multiple organ failure. Leukocytes are the major cell population that participate in the propagation of the disease. Current understanding of the course of AP is still far from complete, limiting treatment options mostly to conservative supportive care. Emerging evidence has pointed to modulation of the immune system for strategic therapeutic development, by mitigating the inflammatory response and severity of AP. In the current review, we have focused on the role of innate immunity in the condition and highlighted therapeutics targeting it for treatment of this challenging disease.
  
  
  METHODS
  The current review has aimed to elaborate in-depth understanding of specific roles of innate immune cells, derived mediators and inflammatory pathways that are involved in AP. Summarizing the recent therapeutics and approaches applied experimentally that target immune responses to attenuate AP.
  
  
  CONCLUSIONS
  The current state of knowledge on AP, limitations of presently available therapeutic approaches and the promise of therapeutic implications of innate immune system in AP are discussed.
authors.affiliation: a 1 Jiangnan University, School of Food Science and Technology, The Synergetic Innovation Center of Food Safety and Nutrition, State Key Laboratory of Food Science and Technology , Wuxi, Jiangsu, China jiasun@jiangnan.edu.cn.
authors.forename: Muhammad
authors.initials: M
authors.lastname: Shamoon
authors.affiliation: a 1 Jiangnan University, School of Food Science and Technology, The Synergetic Innovation Center of Food Safety and Nutrition, State Key Laboratory of Food Science and Technology , Wuxi, Jiangsu, China jiasun@jiangnan.edu.cn.
authors.forename: Yuanyuan
authors.initials: Y
authors.lastname: Deng
authors.affiliation: a 1 Jiangnan University, School of Food Science and Technology, The Synergetic Innovation Center of Food Safety and Nutrition, State Key Laboratory of Food Science and Technology , Wuxi, Jiangsu, China jiasun@jiangnan.edu.cn.
authors.forename: Yong Q
authors.initials: YQ
authors.lastname: Chen
authors.affiliation: b 2 University of Otago, Inflammation Research Group, Department of Pathology , Christchurch, 2 Riccarton Avenue, P.O. Box 4345, Christchurch 8140, New Zealand madhav.bhatia@otago.ac.nz.
authors.forename: Madhav
authors.initials: M
authors.lastname: Bhatia
authors.affiliation: a 1 Jiangnan University, School of Food Science and Technology, The Synergetic Innovation Center of Food Safety and Nutrition, State Key Laboratory of Food Science and Technology , Wuxi, Jiangsu, China jiasun@jiangnan.edu.cn.
authors.forename: Jia
authors.initials: J
authors.lastname: Sun
mesh_terms: D000208:Acute Disease; D000818:Animals; D015195:Drug Design; D006801:Humans; D007113:Immunity, Innate / Q000276:immunology*; D018836:Inflammation Mediators / Q000378:metabolism; D007962:Leukocytes / Q000276:immunology; D058990:Molecular Targeted Therapy; D010195:Pancreatitis / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D012720:Severity of Illness Index
chemical_list: D018836:Inflammation Mediators
keywords: acute pancreatitis; inflammatory mediators; innate immunity; leukocyte; therapeutics